Astria Therapeutics
ATXS
ATXS
26 hedge funds and large institutions have $23.9M invested in Astria Therapeutics in 2019 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 6 increasing their positions, 6 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
0% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 6
32% less capital invested
Capital invested by funds: $35.1M → $23.9M (-$11.3M)
Holders
26
Holding in Top 10
1
Calls
$6.08M
Puts
–
Top Buyers
| 1 | +$353K | |
| 2 | +$330K | |
| 3 | +$60.1K | |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$43K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$38.1K |
Top Sellers
| 1 | -$171K | |
| 2 | -$170K | |
| 3 | -$163K | |
| 4 |
JPMorgan Chase & Co
New York
|
-$60.8K |
| 5 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
-$54K |